This is out Library. Please click on the article title to view the details.
submitted by: admin on 06/18/2016
In a field plagued by frequent controversy, the American Cancer Society (ACS) claims to have taken a major step forward to provide transparency in how justified it is in recommending cancer screening tests. It blames oncologists with a conflict of interest...what would you expect from an organization that depends on income from big pharma and the mammography...
submitted by: admin on 11/24/2024
Between 30 and 50% of new breast cancer diagnoses are found on mammography screenings and are classified as ductal carcinoma in situ, or DCIS. Most of these "cancers" are not cancer at all. In fact about 97% are benign lesions that can be followed over time quite safely. Most cases of DCIS would be better off under-diagnosed and under-treated.
Unfortunately,...
submitted by: admin on 09/21/2013
Yale School of Medicine researchers found a clinical trial with neurontin was a seeding trial used by Big Pharma to promote the drug and increase prescriptions. Seeding trials are not illegal but are unethical because they offer no research. They took advantage of 2700 patients and 772 investigators to complete the publication. These people gained nothing for...
submitted by: admin on 07/09/2016
Women diagnosed with ductal carcinoma in situ (DCIS) are confused about whether or not DCIS is cancer or not. MDs are no different! About 2% of DCIS cancers are lethal and the other 98% will die with it and not from it. Twenty to twenty five percent of all breast cancers are DCIS. Mainstream treatment for this condition includes surgery, radiation,...
submitted by: admin on 02/17/2015
There is considerable confusion about the role of mammograms in breast cancer detection in premenopausal women. The US is the only country in the world making the recommendation that they be done on women under the age of 50. The people standing to profit from doing mammograms in this age group are the mammogram industry, Big Pharma in the sale of chemotherapy,...
submitted by: admin on 04/01/2014
In a paper presented at the European Breast Cancer Conference on March 21, 2014, studies out of the Netherlands concluded that doing mammograms in women from age 70-75 as a screening test did not reduce the incidence of advanced stage breast cancer or save lives. They did report that doing mammograms in this age group led to unnecessary overdiagnosis and overtreatment...